Paradigm Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,050
| Closed | -$377K | – | 323 |
|
|
2021
Q2 | $377K | Sell |
2,050
-200
| -9% | -$36.7K | 0.1% | 283 |
|
|
2021
Q1 | $344K | Sell |
2,250
-200
| -8% | -$30.6K | 0.09% | 287 |
|
|
2020
Q4 | $383K | Buy |
2,450
+700
| +40% | +$109K | 0.11% | 278 |
|
|
2020
Q3 | $200K | Hold |
1,750
| – | – | 0.06% | 322 |
|
|
2020
Q2 | $196K | Buy |
+1,750
| New | +$196K | 0.06% | 326 |
|
|
2019
Q2 | – | Sell |
-300
| Closed | -$40.6K | – | 436 |
|
|
2019
Q1 | $40.6K | Sell |
300
-150
| -33% | -$20.3K | 0.01% | 362 |
|
|
2018
Q4 | $43.8K | Sell |
450
-150
| -25% | -$14.6K | 0.01% | 357 |
|
|
2018
Q3 | $83.4K | Buy |
600
+50
| +9% | +$6.95K | 0.02% | 343 |
|
|
2018
Q2 | $68.3K | Hold |
550
| – | – | 0.02% | 340 |
|
|
2018
Q1 | $61.3K | Hold |
550
| – | – | 0.02% | 344 |
|
|
2017
Q4 | $65.8K | Buy |
550
+50
| +10% | +$5.98K | 0.02% | 343 |
|
|
2017
Q3 | $70.1K | Hold |
500
| – | – | 0.02% | 347 |
|
|
2017
Q2 | $60.8K | Sell |
500
-850
| -63% | -$103K | 0.01% | 495 |
|
|
2017
Q1 | $164K | Buy |
+1,350
| New | +$164K | 0.03% | 411 |
|
|
2015
Q1 | – | Sell |
-2,540
| Closed | -$470K | – | 861 |
|
|
2014
Q4 | $470K | Hold |
2,540
| – | – | 0.06% | 323 |
|
|
2014
Q3 | $421K | Sell |
2,540
-200
| -7% | -$33.2K | 0.06% | 335 |
|
|
2014
Q2 | $428K | Hold |
2,740
| – | – | 0.06% | 347 |
|
|
2014
Q1 | $417K | Hold |
2,740
| – | – | 0.06% | 349 |
|
|
2013
Q4 | $365K | Sell |
2,740
-1,550
| -36% | -$206K | 0.06% | 394 |
|
|
2013
Q3 | $498K | Hold |
4,290
| – | – | 0.08% | 267 |
|
|
2013
Q2 | $396K | Buy |
+4,290
| New | +$396K | 0.07% | 340 |
|